{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T18:35:32Z","timestamp":1763058932999},"reference-count":30,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,6,30]]},"DOI":"10.7759\/cureus.41202","type":"journal-article","created":{"date-parts":[[2023,6,30]],"date-time":"2023-06-30T15:47:14Z","timestamp":1688140034000},"source":"Crossref","is-referenced-by-count":3,"title":["Evaluation and Determination of Quantitative Hepatitis B Surface Antigen Diagnostic Performance in Chronic Hepatitis B Virus-Infected Patients"],"prefix":"10.7759","author":[{"given":"S M Rashed Ul","family":"Islam","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Umme","family":"Shahera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Munira","family":"Jahan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shahina","family":"Tabassum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/s1473-3099(02)00315-8","article-title":"Global control of hepatitis B virus infection","volume":"2","author":"Kao JH","year":"2002","unstructured":"Kao JH, Chen DS. Global control of hepatitis B virus infection. Lancet Infect Dis. 2002, 2:395-403. 10.1016\/s1473-3099(02)00315-8","journal-title":"Lancet Infect Dis"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1186\/1743-422X-3-23","article-title":"Application of real-time PCR to quantify hepatitis B virus DNA in chronic carriers in The Gambia","volume":"3","author":"Mendy ME","year":"2006","unstructured":"Mendy ME, Kaye S, van der Sande M, et al.. Application of real-time PCR to quantify hepatitis B virus DNA in chronic carriers in The Gambia. Virol J. 2006, 3:23. 10.1186\/1743-422X-3-23","journal-title":"Virol J"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1586\/17474124.2.4.553","article-title":"Diagnosis of hepatitis B virus infection through serological and virological markers","volume":"2","author":"Kao JH","year":"2008","unstructured":"Kao JH. Diagnosis of hepatitis B virus infection through serological and virological markers. Expert Rev Gastroenterol Hepatol. 2008, 2:553-62. 10.1586\/17474124.2.4.553","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1001\/jama.295.1.65","article-title":"Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level","volume":"295","author":"Chen CJ","year":"2006","unstructured":"Chen CJ, Yang HI, Su J, et al.. Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level. JAMA. 2006, 295:65-73. 10.1001\/jama.295.1.65","journal-title":"JAMA"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1111\/j.1478-3231.2005.01134.x","article-title":"Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2005 update","volume":"25","author":"Liaw YF","year":"2005","unstructured":"Liaw YF, Leung N, Guan R, et al.. Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2005 update. Liver Int. 2005, 25:472-89. 10.1111\/j.1478-3231.2005.01134.x","journal-title":"Liver Int"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2006.03.017","article-title":"Chronic hepatitis B: current testing strategies","volume":"4","author":"Gish RG","year":"2006","unstructured":"Gish RG, Locarnini SA. Chronic hepatitis B: current testing strategies. Clin Gastroenterol Hepatol. 2006, 4:666-76. 10.1016\/j.cgh.2006.03.017","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1007\/s00535-012-0668-y","article-title":"Clinical utility of quantitative HBsAg in natural history and nucleos(t)ide analogue treatment of chronic hepatitis B: new trick of old dog","volume":"48","author":"Tseng TC","year":"2013","unstructured":"Tseng TC, Kao JH. Clinical utility of quantitative HBsAg in natural history and nucleos(t)ide analogue treatment of chronic hepatitis B: new trick of old dog. J Gastroenterol. 2013, 48:13-21. 10.1007\/s00535-012-0668-y","journal-title":"J Gastroenterol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2004.12.015","article-title":"New insight on hepatitis B virus persistence from the study of intrahepatic viral cccDNA","volume":"42","author":"Zoulim F","year":"2005","unstructured":"Zoulim F. New insight on hepatitis B virus persistence from the study of intrahepatic viral cccDNA. J Hepatol. 2005, 42:302-8. 10.1016\/j.jhep.2004.12.015","journal-title":"J Hepatol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/S0973-6883(12)60084-X","article-title":"HBsAg quantification in clinical practice","volume":"2","author":"Seth AK","year":"2012","unstructured":"Seth AK. HBsAg quantification in clinical practice. J Clin Exp Hepatol. 2012, 2:75-80. 10.1016\/S0973-6883(12)60084-X","journal-title":"J Clin Exp Hepatol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1111\/hepr.12630","article-title":"Do hepatic flares really promote rapid decline of serum hepatitis B surface antigen (HBsAg) in patients with HBsAg seroclearance?","volume":"46","author":"Karag\u00f6z E","year":"2016","unstructured":"Karag\u00f6z E. Do hepatic flares really promote rapid decline of serum hepatitis B surface antigen (HBsAg) in patients with HBsAg seroclearance?. Hepatol Res. 2016, 46:719. 10.1111\/hepr.12630","journal-title":"Hepatol Res"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1002\/hep.23803","article-title":"A longitudinal study on the natural history of serum hepatitis B surface antigen changes in chronic hepatitis B","volume":"52","author":"Chan HL","year":"2010","unstructured":"Chan HL, Wong VW, Wong GL, Tse CH, Chan HY, Sung JJ. A longitudinal study on the natural history of serum hepatitis B surface antigen changes in chronic hepatitis B. Hepatology. 2010, 52:1232-41. 10.1002\/hep.23803","journal-title":"Hepatology"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcv.2014.05.013","article-title":"Quantification of hepatitis B surface antigen with the novel DiaSorin LIAISON XL Murex HBsAg Quant: correlation with the ARCHITECT quantitative assays","volume":"60","author":"Burdino E","year":"2014","unstructured":"Burdino E, Ruggiero T, Proietti A, et al.. Quantification of hepatitis B surface antigen with the novel DiaSorin LIAISON XL Murex HBsAg Quant: correlation with the ARCHITECT quantitative assays. J Clin Virol. 2014, 60:341-6. 10.1016\/j.jcv.2014.05.013","journal-title":"J Clin Virol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.5005\/jp-journals-10018-1121","article-title":"Evaluation of a rapid one-step real-time PCR method as a high-throughput screening for quantification of hepatitis B virus DNA in a resource-limited setting","volume":"5","author":"Rashed-Ul Islam SM","year":"2015","unstructured":"Rashed-Ul Islam SM, Jahan M, Tabassum S. Evaluation of a rapid one-step real-time PCR method as a high-throughput screening for quantification of hepatitis B virus DNA in a resource-limited setting. Euroasian J Hepatogastroenterol. 2015, 5:11-5. 10.5005\/jp-journals-10018-1121","journal-title":"Euroasian J Hepatogastroenterol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1007\/s12072-015-9675-4","article-title":"Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update","volume":"10","author":"Sarin SK","year":"2016","unstructured":"Sarin SK, Kumar M, Lau GK, et al.. Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update. Hepatol Int. 2016, 10:1-98. 10.1007\/s12072-015-9675-4","journal-title":"Hepatol Int"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.5152\/tjg.2014.5711","article-title":"Relation between serum quantitative HBsAg, ALT and HBV DNA levels in HBeAg negative chronic HBV infection","volume":"25 Suppl 1","author":"G\u00fcnal \u00d6","year":"2014","unstructured":"G\u00fcnal \u00d6, Barut \u015e, Etikan \u0130, Duygu F, Tuncel U, S\u00fcnb\u00fcl M. Relation between serum quantitative HBsAg, ALT and HBV DNA levels in HBeAg negative chronic HBV infection. Turk J Gastroenterol. 2014, 25 Suppl 1:142-6. 10.5152\/tjg.2014.5711","journal-title":"Turk J Gastroenterol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.3851\/IMP1696","article-title":"Serum hepatitis B surface antigen concentration correlates with HBV DNA level in patients with chronic hepatitis B","volume":"15","author":"Su TH","year":"2010","unstructured":"Su TH, Hsu CS, Chen CL, et al.. Serum hepatitis B surface antigen concentration correlates with HBV DNA level in patients with chronic hepatitis B. Antivir Ther. 2010, 15:1133-9. 10.3851\/IMP1696","journal-title":"Antivir Ther"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2016.08.009","article-title":"The role of quantitative hepatitis B surface antigen revisited","volume":"66","author":"Cornberg M","year":"2017","unstructured":"Cornberg M, Wong VW, Locarnini S, Brunetto M, Janssen HL, Chan HL. The role of quantitative hepatitis B surface antigen revisited. J Hepatol. 2017, 66:398-411. 10.1016\/j.jhep.2016.08.009","journal-title":"J Hepatol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1007\/s12664-013-0395-1","article-title":"Serum HBsAg quantification in treatment-na\u00efve Indian patients with chronic hepatitis B","volume":"33","author":"Ramachandran J","year":"2014","unstructured":"Ramachandran J, Ismail AM, Chawla G, Fletcher GJ, Goel A, Eapen CE, Abraham P. Serum HBsAg quantification in treatment-na\u00efve Indian patients with chronic hepatitis B. Indian J Gastroenterol. 2014, 33:131-5. 10.1007\/s12664-013-0395-1","journal-title":"Indian J Gastroenterol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.5812\/ARCHCID.13306","article-title":"Correlation of quantitative assay of HBsAg and hepatitis B virus DNA levels among chronic HBV patients attending pathologist Lancet Laboratory in Nairobi, Kenya","volume":"12","author":"Mathai F","year":"2017","unstructured":"Mathai F, Otieno Ngayo M, Muturi Karanja S, et al.. Correlation of quantitative assay of HBsAg and hepatitis B virus DNA levels among chronic HBV patients attending pathologist Lancet Laboratory in Nairobi, Kenya. Arch Clin Infect Dis. 2017, 12:e13306. 10.5812\/ARCHCID.13306","journal-title":"Arch Clin Infect Dis"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.2010.078832","article-title":"Correlation between quantitative serum HBsAg and HBV DNA test in Korean patients who showed high level of HBsAg","volume":"63","author":"Lee JH","year":"2010","unstructured":"Lee JH, Kim SJ, Ahn SH, Lee J, Park Y, Kim HS. Correlation between quantitative serum HBsAg and HBV DNA test in Korean patients who showed high level of HBsAg. J Clin Pathol. 2010, 63:1027-31. 10.1136\/jcp.2010.078832","journal-title":"J Clin Pathol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.jceh.2016.07.002","article-title":"Clinical significance of quantitative HBsAg titres and its correlation with HBV DNA levels in the natural history of hepatitis B virus infection","volume":"6","author":"Karra VK","year":"2016","unstructured":"Karra VK, Chowdhury SJ, Ruttala R, Polipalli SK, Kar P. Clinical significance of quantitative HBsAg titres and its correlation with HBV DNA levels in the natural history of hepatitis B virus infection. J Clin Exp Hepatol. 2016, 6:209-15. 10.1016\/j.jceh.2016.07.002","journal-title":"J Clin Exp Hepatol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0043087","article-title":"High hepatitis B surface antigen levels predict insignificant fibrosis in hepatitis B e antigen positive chronic hepatitis B","volume":"7","author":"Seto WK","year":"2012","unstructured":"Seto WK, Wong DK, Fung J, et al.. High hepatitis B surface antigen levels predict insignificant fibrosis in hepatitis B e antigen positive chronic hepatitis B. PLoS One. 2012, 7:e43087. 10.1371\/journal.pone.0043087","journal-title":"PLoS One"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2005.11.016","article-title":"Predicting cirrhosis risk based on the level of circulating hepatitis B viral load","volume":"130","author":"Iloeje UH","year":"2006","unstructured":"Iloeje UH, Yang HI, Su J, Jen CL, You SL, Chen CJ. Predicting cirrhosis risk based on the level of circulating hepatitis B viral load. Gastroenterology. 2006, 130:678-86. 10.1053\/j.gastro.2005.11.016","journal-title":"Gastroenterology"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.14.5448","article-title":"Clinical, virologic and phylogenetic features of hepatitis B infection in Iranian patients","volume":"14","author":"Bahramali G","year":"2008","unstructured":"Bahramali G, Sadeghizadeh M, Amini-Bavil-Olyaee S, et al.. Clinical, virologic and phylogenetic features of hepatitis B infection in Iranian patients. World J Gastroenterol. 2008, 14:5448-53. 10.3748\/wjg.14.5448","journal-title":"World J Gastroenterol"},{"key":"ref25","article-title":"[A comparison of clinical and virological characteristics of 1686 cases of HBeAg-negative and HBeAg-positive chronic hepatitis B]","volume":"44","author":"Yang C","year":"2005","unstructured":"Yang C, Yu Y, Chen J, et al.. [A comparison of clinical and virological characteristics of 1686 cases of HBeAg-negative and HBeAg-positive chronic hepatitis B]. Zhonghua Nei Ke Za Zhi. 2005, 44:648-51.","journal-title":"Zhonghua Nei Ke Za Zhi"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2017.03.021","article-title":"EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection","volume":"67","year":"2017","unstructured":"EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection. J Hepatol. 2017, 67.370-98. 10.1016\/j.jhep.2017.03.021","journal-title":"J Hepatol"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2011.11.030","article-title":"Follow-up and indications for liver biopsy in HBeAg-negative chronic hepatitis B virus infection with persistently normal ALT: a systematic review","volume":"57","author":"Papatheodoridis GV","year":"2012","unstructured":"Papatheodoridis GV, Manolakopoulos S, Liaw YF, Lok A. Follow-up and indications for liver biopsy in HBeAg-negative chronic hepatitis B virus infection with persistently normal ALT: a systematic review. J Hepatol. 2012, 57:196-202. 10.1016\/j.jhep.2011.11.030","journal-title":"J Hepatol"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.23461","article-title":"Serum hepatitis B surface antigen is correlated with intrahepatic total HBV DNA and cccDNA in treatment-na\u00efve patients with chronic hepatitis B but not in patients with HBV related hepatocellular carcinoma","volume":"85","author":"Wang M","year":"2013","unstructured":"Wang M, Qiu N, Lu S, et al.. Serum hepatitis B surface antigen is correlated with intrahepatic total HBV DNA and cccDNA in treatment-na\u00efve patients with chronic hepatitis B but not in patients with HBV related hepatocellular carcinoma. J Med Virol. 2013, 85:219-27. 10.1002\/jmv.23461","journal-title":"J Med Virol"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.4103\/1319-3767.121035","article-title":"Correlation between hepatitis B surface antigen titers and HBV DNA levels","volume":"19","author":"Alghamdi A","year":"2013","unstructured":"Alghamdi A, Aref N, El-Hazmi M, et al.. Correlation between hepatitis B surface antigen titers and HBV DNA levels. Saudi J Gastroenterol. 2013, 19:252-7. 10.4103\/1319-3767.121035","journal-title":"Saudi J Gastroenterol"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.4103\/0255-0857.96664","article-title":"Serum hepatitis B surface antigen levels correlate with high serum HBV DNA levels in patients with chronic hepatitis B: a cross-sectional study","volume":"30","author":"Gupta E","year":"2012","unstructured":"Gupta E, Kumar A, Choudhary A, Kumar M, Sarin SK. Serum hepatitis B surface antigen levels correlate with high serum HBV DNA levels in patients with chronic hepatitis B: a cross-sectional study. Indian J Med Microbiol. 2012, 30:150-4. 10.4103\/0255-0857.96664","journal-title":"Indian J Med Microbiol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/162477-evaluation-and-determination-of-quantitative-hepatitis-b-surface-antigen-diagnostic-performance-in-chronic-hepatitis-b-virus-infected-patients","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:01:33Z","timestamp":1707508893000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/162477-evaluation-and-determination-of-quantitative-hepatitis-b-surface-antigen-diagnostic-performance-in-chronic-hepatitis-b-virus-infected-patients"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,30]]},"references-count":30,"URL":"https:\/\/doi.org\/10.7759\/cureus.41202","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6,30]]}}}